{"SPADE_N_14454": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14454", "Peptide Name": "Brevinin-1pl (natural AMPs; frog, amphibians, animals; XXU; 1S=S, UCSS1a; BBL)", "Source": "skin secretions, the northern leopard frog,Rana pipiens, North America", "Family": "Not found", "Gene": "Not found", "Sequence": "FFPIVAGVAAKVLKKIFCTISKKC", "Sequence Length": 24, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-MRSA", "Hemolytic", "Anticancer"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 2612.29, "PI": 9.9, "Hydrophobicity": 1.07, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Wang J, Hu J, Pu W, Chen X, Ma C, Jiang Y, Wang T, Chen T, Shaw C, Zhou M, Wang L. 2024", "Reference": "Comput Struct Biotechnol J. 2024 Sep 19;23:3391-3406. doi: 10.1016/j.csbj.2024.09.006.PubMed", "Title": "Discovery, Development and Optimisation of a Novel Frog Antimicrobial Peptide with Combined Mode of Action Against Drug-resistant Bacteria"}], "Frequent Amino Acids": "KAF", "Absent Amino Acids": "DEHMNOQRUWY", "Basic Residues": 5, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 15, "Positive Residues": 5, "Negative Residues": 0, "Net Charge": 5, "Comments": "Sequence analysis: APD analysis reveals that this sequence is unique and shows only very low similarity (87.5%) toBrevinin-1SCActivity: S. aureus NCTC 6538 or MRSA 12,493 (MIC 2 uM), E. faecium NCTC 12,697 (MIC 4 uM), E. coli ATCC 8739 (MIC 4 uM), K. pneumoniae ATCC 43,816 (MIC 8 uM), P. aeruginosa ATCC CRM 9027 (MIC 8 uM), A. baumannii BAA 747 (MIC 8 uM), and C.albicans ATCC 10,231 (MIC >128 uM). MBC same or slightly higher.Antimicrobial robustness: NaCl-sensitive: E. coli-dependent (150 mM), KCl-insensitive: E. coli (4.5 mM); CaCl2-sensitive: E. coli-dependent (2 mM); MgCl2-insensitive: E. coli-dependent (1 mM); ZnCl2-insensitive: E. coli (8 uM); NH4Cl-insensitive: E. coli (6 uM); FeCl3-insensitive: E. coli (4 uM).Structure: random coil in buffer NH4Ac and helical in 50% TFE or LPS.In vitro toxicity: horse RBC: HC50 37.64 uM, hemolytic. Less toxic to HaCaT skin cells (IC50 62.71 uM). Also showed effects on both H838 (IC50 6.88 uM) and MCF-7 (IC50 7.6 uM) cancer cell lines.", "Similar Sequences": [{"SPADE_ID": "SPADE_N_14455", "Similarity": 0.9583333333333334, "Sequence": "FFPKVAGVAAKVLKKIFCTISKKC"}, {"SPADE_ID": "SPADE_UN_26541", "Similarity": 0.9583333333333334, "Sequence": "FFPKVAGVAAKVLKKIFCTISKKC"}, {"SPADE_ID": "SPADE_N_14459", "Similarity": 0.9565217391304348, "Sequence": "FFPKVAGVAAKVLKKFCTISKKC"}]}}}